1 |
Gay F, Palumbo A. Management of older patients with multiple myeloma[J]. Blood Rev, 2011, 25(2): 65-73.
|
2 |
Hideshima T, Mitsiades C, Tonon G, et al. Understanding multiple myeloma pathogenesis in the bone marrowto identify new therapeutic targets[J]. Nat Rev Cancer, 2007, 7 (8):585-598.
|
3 |
Keating A. Mesenchymal stromal cells: new directions[J]. Cell stem cell, 2012, 10(6):709-716.
|
4 |
Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation[J]. Annu Rev Pathol, 2011, 6:457-478.
|
5 |
陈亚芳. 间充质干细胞通过分泌趋化因子CXCL13调节骨髓瘤细胞的侵袭及耐药作用[D]. 天津:天津医科大学, 2017.
|
6 |
Xu S, Menu E, De Becker A, et al. Bone marrow-derived mesenchymal stromal cells are attracted by multiplemyeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo[J]. Stem Cells, 2012, 30(2):266-279.
|
7 |
陈燕. IL-17A促进骨髓瘤间充质干细胞成骨分化研究[D]. 福州:福建医科大学, 2018.
|
8 |
蔡啸, 扆雪涛, 姚菁青, 等. 人骨髓间充质干细胞分泌的外泌体调控恶性胶质瘤相关巨噬细胞的极化[J].昆明医科大学学报, 2021, 42(1):38-45.
|
9 |
邓震. 骨髓间充质干细胞通过mi R-29c抑制前列腺癌细胞的功能及机制研究[D]. 上海:第二军医大学, 2014.
|
10 |
Xu X, Yang J, Tang Y, et al. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib[J]. Int J Clin Exp Pathol, 2014, 7(10):6705-6715.
|
11 |
Wang X, Zhang Z, Yao C. Angiogenic activity of mesenchymal stem cells in multiple myeloma[J]. Cancer Invest, 2011, 29(1):37-41.
|
12 |
Shyh-Chang N, Daley GQ,Cantley LC. Stem cell metabolism in tissue development and aging[J]. Development, 2013, 140(12): 2535-2547.
|
13 |
Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model[J]. J Cell Sci, 2000, 113:1161-1166.
|
14 |
Zhang M, Methot D, Poppa V, et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies[J]. J Mol Cell Cardiol, 2001, 33(5):907-921.
|
15 |
lyer S, Brooks R, Gumbleton M, et al. SHIP1-expressing mesenchymal stem cells regulate hematopoietic stem cell homeostasis and lineage commitment during aging[J]. Stem Cells Dev, 2015, 24(9): 1073-1081.
|
16 |
Alessio N, Stellavato A, Squillaro T, et al. Hybrid complexes of high and low molecular weight hyaluronan delay in vitro replicative senescence of mesenchymal stromal cells: a pilot study for future therapeutic application[J]. Aging (Abany NY), 2018, 10(7):1575-1585.
|
17 |
Passtoors WM, Boer JM, Goeman JJ, et al. Transcriptional profiling of human familial longevity indicates a role for ASF1A and IL7R[J]. PLoS One, 2012, 7(1):e27759. doi: 10.1371/journal.pone.0027759.
|
18 |
Piao J, Sun J, Yang Y, et al. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis[J]. Gene, 2018, 647: 306-311.
|
19 |
Anitha P, Anbarasu A, Ramaiah S. Gene network analysis reveals the association of important functional partners involved in antibiotic resistance: a report on an important pathogenic bacterium Staphylococcus aureus[J]. Gene, 2016, 575:253-263.
|
20 |
Gao LM, Xie CY, Zhang TY, et al. Maternal supplementation with calcium varying with feeding time daily during late pregnancy affects lipid metabolism and transport of placenta in pigs[J]. Biochem Biophys Res Commun, 2018, 505(2):624-630.
|
21 |
Li J, Zhou Y, Du G, et al. Integration of transcriptomics and network analysis deciphers the mechanisms of baicalein in improving learning and memory impairment in senescence-accelerated mouse prone 8 (SAMP8) [J]. Eur J Pharmacol, 2019, 865:172789. doi: 10.1016/j.ejphar.2019.172789.
|
22 |
詹渊博, 刘昕朋, 许文霞, 等. 组蛋白去乙酰化酶9在骨髓间充质干细胞衰老过程中的表达[J]. 中国组织工程研究, 2022, 26(30): 4762-4766.
|
23 |
麦丽萍, 何国东, 陈少贤, 等. 乙醛脱氢酶3B1在人骨髓间充质干细胞自然衰老过程中的表达[J]. 中国组织工程研究, 2022, 26(1): 40-44.
|
24 |
Xin Z, Ma Z, Hu W, et al. FOXO1/3: potential suppressors of fibrosis[J]. Ageing Res Rev, 2018, 41:42-52.
|
25 |
Yadav RK, Chauhan AS, Zhuang L, et al. Foxo transcription factors in cancer metabolism[J]. Semin Cancer Biol, 2018, 50:65-76.
|
26 |
吴平平, 胡文龙, 殷嫦嫦, 等. FOXO4通过抑制凋亡维持人脐带间充质干细胞衰老[J]. 生理学报, 2020, 72(4):426-432.
|
27 |
Wilson MS, Brosens JJ, Schwenen HD, et al. FOXO and FOXM1 in cancer: the FOXO-FOXM1 axis shapes the outcome of cancer chemotherapy[J]. Curr Drug Targets, 2011, 12(9):1256-1266.
|
28 |
张胜. 山奈酚通过调控FoxO通路抑制氧化应激介导的间充质干细胞凋亡机制研究[D]. 南昌:南昌大学, 2016.
|
29 |
马林. miR-223-3p调控人骨髓间充质干细胞成骨分化的机制研究[D]. 昆明:昆明医科大学, 2020.
|
30 |
Adamopoulos IE, Chao CC, Geissler R, et al. Interleukin-17A upregulates receptor activator of NF-KB on osteoclast precursors[J]. Arthritis Res Ther, 2010, 12(1):R29. doi: 10.1186/ar2936.
|
31 |
Miyauchi H, Minamino T, Tateno K, et al. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway[J]. EMBO J, 2004, 23(1):212-220.
|
32 |
Foo SL, Yap G, Cui J, et al. Annexin-A1- A blessing or a curse in cancer?[J]. Trends Mol Med, 2019, 25(4):315-327.
|
33 |
游沁怡, 柯一郎, 洪华山. 膜联蛋白A1与衰老及其相关性疾病的研究进展[J]. 中华老年医学杂志, 2021, 40(3):383-387.
|
34 |
Rimokh R, Rouault JP, Wahbi K, et al. A chromosome 12 coding reg1on is juxtaposed to the MYC protooncogene locus in at(8;12)(q24;q22)translocation in a case of B-cell chronic lymphocytic leukemia[J]. Genes Chromosomes Cancer, 1991, 3(1):24-36.
|
35 |
Cho JW, Kim JJ, Park SG, et al. Identification of B-cell translocation gene 1 as a biomarker for monitoring the remission of acute myeloid leukemia[J]. Proteomics, 2004, 4 (11):3456-3463.
|
36 |
Kimura H, Fumoto K, Shojima K, et al. CKAP4 is a Dickkopf1 receptor and is involved in tumor progression[J]. J Clin Invest, 2016, 126(7):2689-2705.
|
37 |
Hobbs GA, Zhou B, Cox AD, et al. Rho GTPases, oxidation, and cell redox control[J]. Small GTPases, 2014, 5:e28579. doi: 10.4161/sgtp.28579.
|
38 |
Dominguez R,Holmes KC. Actin structure and function[J]. Annu Rev Biophys, 2011, 40:169-186.
|
39 |
Freitas JL, Vale TC, Barsottini OGP, et al. Expanding the phenotype of dystonia-deafness syndrome caused by ACTB gene mutation[J]. Mov Disord Clin Pract, 2019, 7(1):86-87.
|
40 |
Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer[J]. EMBO Rep, 2014, 15(6):642-56.
|
41 |
Terpos E, Ntanasis-Stathopoulos I, Gavriatopoulou M, et al. Pathogenesis of bone disease in multiple myeloma: from bench to bedside[J]. Blood Cancer J, 2018, 8(1):7. doi: 10.1038/s41408-017-0037-4.
|